🇺🇸 FDA
Patent

US 8067636

Dihydrazide compounds, preparation and uses thereof

granted A61PA61P3/02

Quick answer

US patent 8067636 (Dihydrazide compounds, preparation and uses thereof) held by Bioregen Biomedical (Shanghai) Co., Ltd expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Bioregen Biomedical (Shanghai) Co., Ltd
Grant date
Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P3/02